You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 2, February 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Challenges in Otolaryngology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dentistry/ Oral Medicine
 •Radiation Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Commentary on Prophylactic Treatment of Radiation-Induced Xerostomia

Arch Otolaryngol Head Neck Surg. 2003;129:251-252.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Nagler and Baum have presented a concise review of the ongoing research on the mechanisms of radiation-induced damage to salivary glands and the treatment options for radiation-induced xerostomia. In so doing, they have communicated a promising area of research to the scientific community while highlighting their own extensive and provocative contributions to it. Xerostomia is a serious complication of radiation therapy (XRT) that causes many secondary intraoral effects (eg, caries, fungal and microbial infections, altered taste acuity, and dysphagia). Eighty percent of patients with head and neck cancer in the United States receive at least one course of XRT as a component of therapy, and most of them experience xerostomia. Treatment options for irradiation-induced xerostomia are limited. They are determined by dose of irradiation, length of therapy, volume of tissue treated, and the dose of radiation used; involvement of the major salivary gland; and tumor ablative procedures performed before or . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Prophylactic Treatment Reduces the Severity of Xerostomia Following Radiation Therapy for Oral Cavity Cancer
Rafael M. Nagler and Bruce J. Baum
Arch Otolaryngol Head Neck Surg. 2003;129(2):247-250.
EXTRACT | FULL TEXT  

Xerostomia Prevention After Head and Neck Cancer Treatment
Hadi Seikaly
Arch Otolaryngol Head Neck Surg. 2003;129(2):250-251.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.